UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a glial cell-derived neurotrophic factor-releasing artificial dura for neural tissue engineering applications

Journal of materials chemistry. B, Materials for biology and medicine, 2015-01, Vol.3 (4), p.7974-7985

2015

Volltextzugriff (PDF)

Psychological Capital and Work Engagement: The Moderating Role of Job Demands

Vasandani, Resham R

2018

Volltextzugriff (PDF)

Post-translational modification sites are present in hydrophilic cavities of alpha-synuclein, tau, FUS, and TDP-43 fibrils: A molecular dynamics study

Biophysical journal, 2024-02, Vol.123 (3), p.490a-490a

2024

Volltextzugriff (PDF)

Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS, and TDP‐43 fibrils: A molecular dynamics study

Proteins, structure, function, and bioinformatics, 2024-07, Vol.92 (7), p.854-864

2024

Volltextzugriff (PDF)

L’aprémilast améliore l’état des patients atteints du rhumatisme psoriasique de forme oligoarticulaire : analyse principale de l’essai thérapeutique contrôlé vs placebo FOREMOST

Revue du rhumatisme (Ed. française : 1993), 2023-12, Vol.90, p.A190

2023

Volltextzugriff (PDF)

Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics

Neuro-oncology (Charlottesville, Va.), 2024-01, Vol.26 (1), p.127-136

2024

Volltextzugriff (PDF)

Threonine Cavities Are Targetable Motifs That Control Alpha-Synuclein Fibril Growth

ACS chemical neuroscience, 2022-09, Vol.13 (17), p.2646-2657

2022

Volltextzugriff (PDF)

Very Severe Hypertriglyceridemia in a Large US County Health Care System: Associated Conditions and Management

Journal of the Endocrine Society, 2019-08, Vol.3 (8), p.1595-1607

2019

Volltextzugriff (PDF)

Role of the N Terminus in RNase A Homologues: Differences in Catalytic Activity, Ribonuclease Inhibitor Interaction and Cytotoxicity

Journal of molecular biology, 1996-04, Vol.257 (5), p.992-1007

1996

Volltextzugriff (PDF)

Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction

Nature biotechnology, 1999-03, Vol.17 (3), p.265-270

1999

Volltextzugriff (PDF)

D34 AEROSOLIZED MEDICATIONS: SPECIFICATIONS AND TREATMENT CONSIDERATIONS: In Vitro Comparison Of Aerosol Characteristics Of Two Hfa Pmdi Formulations Used In Asthma And COPD With Inspirachamber® And Aerochamber Plus Flow-Vu

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily

Cancer research (Chicago, Ill.), 1996-09, Vol.56 (18), p.4180-4186

1996

Volltextzugriff (PDF)

Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues

Bioorganic & medicinal chemistry, 2007-01, Vol.15 (2), p.702-713

2007

Volltextzugriff (PDF)

Synthesis and interactions of 7-deoxy-, 10-deacetoxy, and 10-deacetoxy-7-deoxypaclitaxel with NCI/ADR-RES cancer cells and bovine brain microvessel endothelial cells

Bioorganic & medicinal chemistry letters, 2006-01, Vol.16 (2), p.433-436

2006

Volltextzugriff (PDF)

Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

British journal of haematology, 1992-10, Vol.82 (2), p.460-466

1992

Volltextzugriff (PDF)

Interferon enhances the activity of the anticancer ribonuclease, onconase

Journal of interferon & cytokine research, 1999-05, Vol.19 (5), p.447-454

1999

Volltextzugriff (PDF)

Oral iron chelation with L1

The Lancet (British edition), 1990-03, Vol.335 (8689), p.601-601

1990

Volltextzugriff (PDF)

DEATHS IN PATIENTS RECEIVING ORAL IRON CHELATOR L1

British journal of haematology, 1993-10, Vol.85 (2), p.430-430

1993

Volltextzugriff (PDF)

Differential thermal analysis of low-rank coals

Journal of thermal analysis, 1994-05, Vol.41 (5), p.1053-1061

1994

Volltextzugriff (PDF)

Efficacy and safety of 1-2, dimethyl-3-hydroxypyrid-4-one (L1) as an oral iron chelator in patients of beta thalassaemia major with iron overload

Journal of the Association of Physicians of India, 1991-09, Vol.39 (9), p.669

1991

Volltextzugriff (PDF)

Long‐term assessment of efficacy and safety of L 1 , an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

British journal of haematology, 1992-10, Vol.82 (2), p.460-466

1992

Volltextzugriff (PDF)

Improving Model Accuracy with Probability Scoring Machine Learning Models

Advances in Data Science and Information Engineering, p.517-530

Volltextzugriff (PDF)

Cell Culture Models for Drug Transport Studies

Drug Delivery, 2005, p.103-124

2005

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Sprache

Englisch
(22)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a glial cell-derived neurotrophic factor-releasing artificial dura for neural tissue engineering applications

Psychological Capital and Work Engagement: The Moderating Role of Job Demands

Post-translational modification sites are present in hydrophilic cavities of alpha-synuclein, tau, FUS, and TDP-43 fibrils: A molecular dynamics study

Post‐translational modification sites are present in hydrophilic cavities of alpha‐synuclein, tau, FUS, and TDP‐43 fibrils: A molecular dynamics study

L’aprémilast améliore l’état des patients atteints du rhumatisme psoriasique de forme oligoarticulaire : analyse principale de l’essai thérapeutique contrôlé vs placebo FOREMOST

Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics

Threonine Cavities Are Targetable Motifs That Control Alpha-Synuclein Fibril Growth

Very Severe Hypertriglyceridemia in a Large US County Health Care System: Associated Conditions and Management

Role of the N Terminus in RNase A Homologues: Differences in Catalytic Activity, Ribonuclease Inhibitor Interaction and Cytotoxicity

Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction

D34 AEROSOLIZED MEDICATIONS: SPECIFICATIONS AND TREATMENT CONSIDERATIONS: In Vitro Comparison Of Aerosol Characteristics Of Two Hfa Pmdi Formulations Used In Asthma And COPD With Inspirachamber® And Aerochamber Plus Flow-Vu

Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily

Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues

Synthesis and interactions of 7-deoxy-, 10-deacetoxy, and 10-deacetoxy-7-deoxypaclitaxel with NCI/ADR-RES cancer cells and bovine brain microvessel endothelial cells

Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

Interferon enhances the activity of the anticancer ribonuclease, onconase

Oral iron chelation with L1

DEATHS IN PATIENTS RECEIVING ORAL IRON CHELATOR L1

Differential thermal analysis of low-rank coals

Efficacy and safety of 1-2, dimethyl-3-hydroxypyrid-4-one (L1) as an oral iron chelator in patients of beta thalassaemia major with iron overload

Long‐term assessment of efficacy and safety of L 1 , an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

Improving Model Accuracy with Probability Scoring Machine Learning Models

Cell Culture Models for Drug Transport Studies

Suchergebnisse filtern